7:30 – 8:00 am CST – Registration and breakfast
8:00 – 9:30 am CST – Roundtable discussion
McDermott Will & Emery LLP
1000 Louisiana Street, Suite 3900
Houston, TX 77002-5005
To view presentation materials, please click here.
In our annual "Year in Review" program, McDermott Will & Emery partners will discuss and analyze the major developments and changes in patent law during 2013 and the key cases to watch in 2014. Our discussion will include:
The Supreme Court of the United State’s decisions in Gunn v. Minton, Bowman v. Monsanto Co., Federal Trade Commission v. Actavis, Inc. and AMP, et al. v. Myriad Genetics, Inc., et al.
The U.S. Court of Appeals for the Federal Circuit’s decisions impacting divided infringement, preliminary injunctions, patent exhaustion, abbreviated new drug application (ANDA) standards of review, intervening rights, claim construction, developments in the law of secondary considerations of non-obviousness and much more
Issues pending review by the U.S. Supreme Court
Practical and case law implications of the continued implementation of the America Invents Act, including trends and statistics for inter partes review and post-grant review
CLE credit is pending in California, Illinois, New York and Texas. A Uniform Certificate of Attendance will be made available to participants requesting CLE credit in all other states.
McDermott Will & Emery's IP Management Roundtables are designed for the educational benefit of a company president, CEO, general counsel or other executive with an interest in intellectual property. Please be advised McDermott has the right to restrict attendance and may limit participation in this event.